Lipid II — Drug Target

All drugs that target Lipid II — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Lipoglycopeptide antibiotic

Phase 3 pipeline (1)

• Single-Dose IV Oritavancin Diphosphate · Melinta Therapeutics, Inc. · Lipoglycopeptide antibiotic · Infectious Diseases
  Oritavancin diphosphate is a lipoglycopeptide antibiotic that inhibits cell wall synthesis in Gram-positive bacteria.